111 (NASDAQ:YI) Shares Up 2.4% – Should You Buy?

111, Inc. Sponsored ADR (NASDAQ:YI) traded up 2.4% during mid-day trading on Monday . The stock traded as high as $8.41 and last traded at $8.38. 12,303 shares were traded during mid-day trading, a decline of 79% from the average session volume of 58,331 shares. The stock had previously closed at $8.18.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of 111 in a research note on Monday, December 29th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, 111 has a consensus rating of “Sell”.

111 Stock Up 2.4%

The company has a 50-day moving average price of $5.26 and a two-hundred day moving average price of $5.05. The stock has a market capitalization of $72.40 million, a P/E ratio of -9.98 and a beta of 0.66.

111 (NASDAQ:YI) last released its quarterly earnings data on Wednesday, December 17th. The company reported ($1.20) EPS for the quarter. The firm had revenue of $421.49 million for the quarter.

About 111

111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.

111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.